Therapeutic Products Act
The passing of this act has implications for individuals and organisations operating within the natural health products industry. FxMed opposes the Therapeutic Products Act (TPA)
Adopt an expansive approach rather than a restrictive one, maintain and enhance freedom of choice for practitioners and consumers. We are in support of the TPA being repealed in favour of a new stand-alone regulation and regulatory body for natural health products.
Since our original submission:
We have conducted an internal review and appended notes to indicate whether any of our suggested changes have been considered.
Summary of key objections:
- Natural Health Products (NHPs) should be regulated separately from the TPA which is a framework primarily designed for medicines, medical devices.
- Regulator should have sound knowledge of Naturopathy, Herbalism and should constitute an expert advisory board drawing upon the skill sets of various practitioner modalities.
- Blacklist ingredients rather than a whitelist approach. Ingredients or Products being sold safely in other countries like USA, EU, Australia etc should be allowed.
- Increase ingredient limits eg Vit B12, Vit D. Thought be given for natural healthcare practitioners to be able to access higher limits.
- Costs and fees must be kept equitable for low-volume products so that these products do not disappear from the market.
Watch FxMed’s 10-minute oral submission opposing the bill presented by our CEO, Amal Karl